Register for OBR daily


IMS_White_300x250

To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

GALE $2.29 0.2100 +10.10%
EPZM $23.35 1.6900 +7.80%
SPPI $7.18 0.2800 +4.06%
BDSI $8.66 0.1900 +2.24%
NYMX $5.24 0.0900 +1.75%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

PARD $0.21 -0.1099 -34.34%
IMNP $3.96 -0.5300 -11.80%
TGTX $5.16 -0.6600 -11.34%
IMMU $4.15 -0.4200 -9.19%
GERN $2.00 -0.1900 -8.68%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | Next > | Last >>

Kathleen Sebelius Steps Down as HHS Secretary; OMB Director Will Take Her Place

(Washington Post) Apr 11, 2014 - Health and Human Services Secretary Kathleen Sebelius is resigning, ending a tumultuous tenure as the public face of the Affordable Care Act. President Obama will nominate his budget director on Friday as her successor, according to White House officials.
read article (free registration required) 



Cancer 'Miracle' Patients Studied Anew for Disease Clues

(Bloomberg) Apr 11, 2014 - The history of oncology is rife with reports of patients with advanced cancer who staged miraculous recoveries.
read article 



Sebelius Resigns After Troubles Over Health Site

(New York Times) Apr 10, 2014 - Kathleen Sebelius, the health and human services secretary, is resigning, ending a stormy five-year tenure marred by the disastrous rollout of President Obama’s signature legislative achievement, the Affordable Care Act.
read article 



Men with Prostate Cancer 'Falsely' Told It Is Not Aggressive

(The Telegraph [UK]) Apr 11, 2014 - Up to half of men diagnosed with prostate cancer are being given “false hope” by tests that are underestimating the severity of their disease, according to the authors of a new study.
read article 



Medicare Reimbursement Data Often Misunderstood

(FCS) Apr 10, 2014 - Florida Cancer Specialists addresses high costs of community oncology.
read press release 



French Plan to Push Copycat Biotech Drugs Worries Big Pharma

(Reuters) Apr 10, 2014 - France is going out on a limb with a plan to push the use of cheap copies of biotech drugs, triggering alarm among companies in Europe's second-biggest pharmaceutical market behind Germany.
read article 



Biogen's Blood Disorder Drug Succeeds in Late-Stage Trial

(Reuters) Apr 10, 2014 - Biogen Idec Inc and Swedish Orphan Biovitrum said their experimental blood disorder drug was effective in treating children with hemophilia in a late-stage trial.
read article 



WHO Releases Global Hepatitis C Treatment Guidelines, Urges Cure Pills Should be Made Affordable

(IB Times) Apr 10, 2014 – The World Health Organization (WHO) on Wednesday urged global governments as well as the world's numerous pharmaceuticals to lower down and make affordable the prices of cure pills for the hepatitis C virus (HCV) as the agency released its first ever global Hepatitis C treatment guidelines.
read article 



Bristol-Myers Reports Positive Results from Hepatitis C Drug Study

(Wall Street Journal) Apr 10, 2014 - Bristol-Myers Squibb Co. said its late-stage study of a hepatitis C treatment achieved positive results in up to 90% of certain patient groups, showing the efficacy of the drug combination.
read article (paid subscription required) 



Merck: Hepatitis C Drug Shows 98% Cure Rate in Mid-Stage Trial

(NASDAQ/Dow Jones Business News) Apr 10, 2014 - Merck & Co. said Thursday that a pair of its hepatitis C virus treatments showed a cure rate of 98% in a mid-stage trial, supporting advancement of the study.
read article 



Report: Exchanges Yield More Specialty Drug Claims

(Boston Herald) Apr 9, 2014 - Patients from the health care overhaul's new insurance exchanges have been more likely to use expensive specialty drugs for chronic conditions, according to data from the nation's largest pharmacy benefits manager.
read article 



Specialty Groups Cautious on Medicare Pay Data

(MedPage Today) Apr 9, 2014 - Whereas most physicians and some medical organizations have responded negatively to public release of providers' Medicare reimbursement data, several professional societies sided cautiously in favor of transparency.
read article (free registration required) 



The Medicare Data’s Pitfalls

(New York Times) Apr 9, 2014 - Many doctors said they favored the sharing of Medicare payment data but worried that it left out important details.
read article 



Medocity Launches iCancerHealth Mobile Platform Helping Cancer Patients

(Reuters) Apr 9, 2014 - Medocity today announced the launch of its flagship product iCancerHealth in the Apple® App Store. The unique patient-centric application utilizes innovative and intelligent mobile solutions and interactive tools to help cancer patients address unmet needs once they leave the physician or hospital setting.
read article 



Local and National Leaders Come Together to Accelerate Cancer Research at the 12th Annual Multiple Myeloma Research Foundation (MMRF) Annual Chicago Awards Dinner

(MMRF) Apr 9, 2014 - More than 400 Chicago business, healthcare and community leaders attended the 12th Annual Multiple Myeloma Research Foundation (MMRF) Chicago Awards Dinner and raised over $800,000 towards research for multiple myeloma.
read press release 



Physicians’ Education Resource Co-Program Director Honored with Lectureship Award

(Yahoo! Finance) Apr 9, 2014 - The Bonnie J. Addario Lung Cancer Foundation (ALCF) announced today the winner of its 2014 Lectureship Award is Dr. Roy Herbst, a medical oncologist at Yale Cancer Center and distinguished co-director of the International Lung Cancer Congress (ILCC).
read article 



Oncologist Wins National Award

(Huntersville Herald [Huntersville, NC]) Apr 10, 2014 - The Association of Community Cancer Centers awarded John Powderly II with the 2014 David King Community Clinical Scientist Award on April 2 at its national meeting.
read article 



Johns Hopkins Researchers Receive Honors and Awards at the American Association for Cancer Research Annual Meeting

(Johns Hopkins Medicine) Apr 9, 2014 - The following announcements are related to awards that have been presented during the American Association for Cancer Research (AACR) Annual Meeting 2014, held in San Diego April 5-9, to researchers at the Johns Hopkins Kimmel Cancer Center.
read press release 



Celsion Announces ThermoDox HCC Program to Be Discussed at the 2014 European Conference on Interventional Oncology in Berlin, Germany

(MarketWatch) Apr 10, 2014 - Professor Riccardo Lencioni is giving an honorary lecture on April 24, 2014 which will highlight the latest findings and lessons learned from the HEAT Study and the design of the Phase III OPTIMA Study.
read article 



Guided Therapeutics Receives May 8th Meeting Date from FDA to Discuss LuViva Advanced Cervical Scan PMA Application

(Yahoo! Finance) Apr 10, 2014 - Guided Therapeutics, Inc. today announced that the company has been given a face-to-face meeting date of May 8, 2014, by the U.S. Food and Drug Administration (FDA), to discuss the company’s response to the September 6, 2013 not-approvable letter that the company received from the agency.
read article 



Hospira Wins UK Case to Overturn Patents on Roche Drug Herceptin

(Reuters) Apr 10, 2014 - Hospira has successfully overturned two patents on Roche's top-selling breast cancer drug Herceptin in Britain, clearing the way for it to launch a cheaper copycat version in the country.
read article 



Aveo to Co-Develop NSCLC Candidate with Biodesix' VeriStrat

(Genetic Engineering News) Apr 10, 2014 - Aveo Oncology and Biodesix said today they will co-develop Aveo’s ficlatuzumab with a Biodesix companion diagnostic already on the market, VeriStrat, to identify patients with advanced non-small cell lung cancer (NSCLC) who would be most likely to benefit from the hepatocyte growth factor (HGF) inhibitory antibody.
read article 



Cuts to NCI’s Budget Threaten the Community Clinical Oncology Program

(ACCCBuzz) Apr 10, 2014 - Due to the Congressional budget-reduction mindset, NCI is woefully underfunded, leading to the National Cancer Institute’s (NCI’s) decision to end funding for federally-funded clinical trials through Community Clinical Oncology Program (CCOP) as of June 1, 2014.
read article 



Newport Doctor Paid $11 Million Says 'Data Dump' Doesn't Tell Whole Story

(Orange County Register) Apr 10, 2014 - When Dr. Minh Nguyen got a phone call from a reporter telling him he’d been paid $11 million from Medicare in 2012, he was shocked.
read article 



COA Issues Statement on Release of Medicare Data

(COA) Apr 10, 2014 - The Community Oncology Alliance (COA) strongly disagrees with the release of physician-specific Medicare reimbursement claims data and the manner in which the Centers for Medicare & Medicaid Services (CMS) released the data.
read press statement